Scroll for more
events Nov 30, 2017

SLUSH 2017

Join Ken Mulvany Founder and Chairman of BenevolentAI for a talk on "Can a machine cure brain disease"

Date

Nov 30, 2017

Time

08:00 AM

Venue

Helsinki

Open in Google Maps >>

Register

Can a machine brain cure disease?

AI has the potential to positively and dramatically change our world.  In healthcare, AI advances are being made in diagnosis and better care but is the technology capable of curing disease?  Ken Mulvany serial healthcare entrepreneur and founder of BenevolentAI, one of the world’s largest private AI companies, will discuss why, despite the huge growth of knowledge and information the process of scientific discovery has not changed for 50 years – until now! how AI is dramatically accelerating the development of new medicines and how, for the first time, a machine brain may have cured a human brain disease.

 

Biography

Ken is a serial entrepreneur, investor, healthcare and technology industry veteran.  He is currently the Chairman of BenevolentAI, a $1.7bn valuation British technology company he founded, which is applying AI to accelerate and enhance scientific discovery.  He was previously CEO of Proximagen, a UK-based biotech company that he founded which was committed to delivering novel drugs and innovative new treatments for central nervous system disorders.  Proximagen was sold to a US pharmaceutical company in 2012 for $555m.  Ken sits on the advisory panel to the UK Government on Artificial Intelligence and is a member of the All Party Artificial Intelligence Parliamentary Group.  He is currently the Chairman of the Trustees of the Cure Parkinson’s Trust.  Ken also sits on the Advisory Board for Oxford Sciences Innovations.  Ken is twice a world champion sailor and competed in the 1992 America’s Cup.